» Articles » PMID: 26106125

Alterations of Oxidative Phosphorylation in Meningiomas and Peripheral Nerve Sheath Tumors

Overview
Journal Neuro Oncol
Specialties Neurology
Oncology
Date 2015 Jun 25
PMID 26106125
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Changes in the mode of aerobic energy production are observed in many solid tumors, though the kinds of changes differ among tumor types. We investigated mitochondrial energy metabolism in meningiomas and peripheral nerve sheath tumors, taking into consideration the histologic heterogeneity of these tumors.

Methods: Oxidative phosphorylation (OXPHOS) complexes and porin (a marker for mitochondrial mass) were analyzed by immunohistochemical staining of meningiomas (n = 76) and peripheral nerve sheath tumors (schwannomas: n = 10; neurofibromas: n = 4). The enzymatic activities of OXPHOS complexes and citrate synthase were determined by spectrophotometric measurement. Western blot analysis of OXPHOS complexes, porin, and mitochondrial transcription factor A was performed. Furthermore, mitochondrial DNA copy number was determined.

Results: The tumors differed with regard to mitochondrial energy metabolism. Low levels of a subset of OXPHOS complexes were frequently observed in World Health Organization grade I meningiomas (percent of cases with a reduction; complex I: 63%; complex II: 67%; complex IV: 56%) and schwannomas (complex III: 40%, complex IV: 100%), whereas in neurofibromas a general reduction of all complexes was observed. In contrast, expression of complexes III and V was similar to that in normal brain tissue in the majority of tumors. Mitochondrial mass was comparable or higher in all tumors compared with normal brain tissue, whereas mitochondrial DNA copy number was reduced.

Conclusions: The reduction of OXPHOS complexes in meningiomas and peripheral nerve sheath tumors has potential therapeutic implications, since respiratory chain-deficient tumor cells might be selectively starved by inhibitors of glycolysis or by ketogenic diet.

Citing Articles

Advanced Hyperpolarized C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI Approach.

Autry A, Vaziri S, Gordon J, Chen H, Kim Y, Dang D Cancers (Basel). 2024; 16(2).

PMID: 38254844 PMC: 10814348. DOI: 10.3390/cancers16020354.


Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas.

Tomanelli M, Florio T, Vargas G, Pagano A, Modesto P Life (Basel). 2023; 13(12).

PMID: 38137885 PMC: 10744527. DOI: 10.3390/life13122284.


Metabolic Tumor Microenvironment Characterization of Contrast Enhancing Brain Tumors Using Physiologic MRI.

Stadlbauer A, Marhold F, Oberndorfer S, Heinz G, Zimmermann M, Buchfelder M Metabolites. 2021; 11(10).

PMID: 34677383 PMC: 8537028. DOI: 10.3390/metabo11100668.


Case Report and Review of the Literature: A New and a Recurrent Variant in the Gene Are Associated With Isolated Lethal Hypertrophic Cardiomyopathy, Hyperlactatemia, and Pulmonary Hypertension in Early Infancy.

Kusikova K, Feichtinger R, Csillag B, Kalev O, Weis S, Duba H Front Pediatr. 2021; 9:660076.

PMID: 33937156 PMC: 8085550. DOI: 10.3389/fped.2021.660076.


Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival.

Pestoni J, Klingeman Plati S, Valdivia Camacho O, Fuse M, Onatunde M, Sparrow N J Biol Chem. 2019; 294(30):11354-11368.

PMID: 31171721 PMC: 6663865. DOI: 10.1074/jbc.RA118.007152.


References
1.
Mawrin C, Perry A . Pathological classification and molecular genetics of meningiomas. J Neurooncol. 2010; 99(3):379-91. DOI: 10.1007/s11060-010-0342-2. View

2.
Morscher R, Aminzadeh-Gohari S, Feichtinger R, Mayr J, Lang R, Neureiter D . Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model. PLoS One. 2015; 10(6):e0129802. PMC: 4459995. DOI: 10.1371/journal.pone.0129802. View

3.
Monleon D, Morales J, Gonzalez-Segura A, Gonzalez-Darder J, Gil-Benso R, Cerda-Nicolas M . Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. Cancer Res. 2010; 70(21):8426-34. DOI: 10.1158/0008-5472.CAN-10-1498. View

4.
Feichtinger R, Neureiter D, Mayr J, Zimmermann F, Berthold F, Jones N . Loss of mitochondria in ganglioneuromas. Front Biosci (Elite Ed). 2011; 3(1):179-86. DOI: 10.2741/e231. View

5.
Zimmermann F, Mayr J, Feichtinger R, Neureiter D, Lechner R, Koegler C . Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors. Front Biosci (Elite Ed). 2011; 3(1):315-25. DOI: 10.2741/e247. View